Hyen Joo Park Selected Research

Hyen Joo Park Research Topics

Disease

31	Neoplasms (Cancer) 01/2023 - 06/2003
11	Colonic Neoplasms (Colon Cancer) 09/2020 - 06/2003
10	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 04/2011
9	Neoplasm Metastasis (Metastasis) 12/2022 - 12/2005
8	Inflammation (Inflammations) 01/2023 - 06/2003
7	Lung Neoplasms (Lung Cancer) 12/2023 - 09/2003
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 10/2011
6	Carcinogenesis 04/2021 - 06/2003
5	Fibrosarcoma 08/2012 - 12/2005
2	Osteoarthritis 01/2022 - 01/2016
2	Edema (Dropsy) 01/2022 - 04/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2018
2	Leukemia 11/2016 - 01/2007
2	Body Weight (Weight, Body) 08/2012 - 10/2011
2	Stomach Neoplasms (Stomach Cancer) 01/2007 - 09/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Intervertebral Disc Displacement (Herniated Disc) 01/2023
1	Intervertebral Disc Degeneration 01/2023
1	Anemia 01/2022
1	Fatigue 01/2022
1	Infections 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Triple Negative Breast Neoplasms 04/2021
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Bone Diseases (Bone Disease) 01/2016

Drug/Important Bio-Agent (IBA)

6	CateninsIBA 09/2020 - 08/2012
6	ErbB Receptors (EGF Receptor)IBA 04/2020 - 10/2011
5	DiterpenesIBA 09/2020 - 10/2011
5	Tyrosine Kinase InhibitorsIBA 04/2020 - 04/2015
4	Gefitinib (Iressa)FDA Link 04/2020 - 11/2012
4	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 12/2005
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2012 - 12/2005
4	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 12/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2011
3	MicroRNAs (MicroRNA)IBA 09/2018 - 01/2017
3	mezereinIBA 01/2015 - 10/2011
3	StilbenesIBA 05/2013 - 01/2011
3	lissamine rhodamine B (sulforhodamine B)IBA 04/2008 - 01/2007
3	Messenger RNA (mRNA)IBA 05/2006 - 12/2005
3	ZincIBA 05/2006 - 12/2005
3	Peptide Hydrolases (Proteases)FDA Link 05/2006 - 12/2005
3	indoleIBA 12/2005 - 09/2003
2	CytokinesIBA 01/2023 - 01/2016
2	Gemcitabine FDA Link 01/2023 - 11/2012
2	shinbaroIBA 01/2023 - 01/2016
2	CarrageenanIBA 01/2022 - 04/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2020 - 11/2012
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 09/2018 - 03/2018
2	LigandsIBA 03/2018 - 10/2011
2	SaponinsIBA 04/2016 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 06/2014
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016 - 08/2012
2	EnzymesIBA 01/2016 - 01/2011
2	LignansIBA 12/2015 - 10/2013
2	TCF Transcription FactorsIBA 07/2013 - 08/2012
2	pinosylvinIBA 05/2013 - 08/2012
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2008 - 02/2007
2	Tissue Inhibitor of Metalloproteinase-2IBA 05/2006 - 12/2005
2	Tissue Inhibitor of MetalloproteinasesIBA 12/2005 - 12/2005
1	AcidsIBA 12/2023
1	Caspase 3 (Caspase-3)IBA 12/2023
1	lanostanoidIBA 12/2023
1	apoptolidin AIBA 03/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	periplocinIBA 01/2023
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2023
1	piceamycinIBA 12/2022
1	pulvomycinIBA 04/2021
1	Docetaxel (Taxotere)FDA Link 04/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2021
1	Kaurane DiterpenesIBA 09/2020
1	nodosinIBA 09/2020
1	imidazoleIBA 01/2020
1	AlkaloidsIBA 01/2020
1	topsentin AIBA 01/2020
1	topsentinIBA 01/2020
1	oxypeucadaninIBA 01/2020
1	Furocoumarins (Furanocoumarins)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2018
1	LDN 193189IBA 09/2018
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 09/2018
1	Bone Morphogenetic Protein ReceptorsIBA 09/2018
1	Mitogen-Activated Protein KinasesIBA 06/2018
1	AMP-Activated Protein KinasesIBA 06/2018
1	dihydrotanshinone IIBA 06/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	esculetinIBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	5- (1- (glucopyranosyloxymethyl)ethenyl)- 2- methyl- 2- cyclohexen- 1- oneIBA 04/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	AntibodiesIBA 01/2016
1	Dinoprostone (PGE2)FDA Link 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016
1	safranine T (safranin)IBA 01/2016

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
2	Oral Administration 04/2014 - 10/2011
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Chemoprevention 03/2018
1	Therapeutics 01/2016